Browsing by Author "Laroche, Cécile"
Now showing items 1-9 of 9
-
Association between diabetes and 1-year adverse clinical outcomes in a multinational cohort of ambulatory patients with chronic heart failure: results from the ESC-HFA Heart Failure Long-Term Registry
Dauriz, Marco; Targher, Giovanni; Laroche, Cécile; Temporelli, Pier Luigi; Ferrari, Roberto; Anker, Stefan; Coats, Andrew; Filippatos, Gerasimos; Crespo-Leiro, María Generosa; Mebazaa, Alexandre; Piepoli, Massimo F.; Maggioni, Aldo P.; Tavazzi, Luigi (American Diabetes Association, 2017-03-02)[Abstract] OBJECTIVE: Diabetes mellitus is associated with an increased risk of cardiovascular disease (CVD) and death. Because the prevalence of diabetes is rising worldwide and chronic heart failure (CHF) is becoming ... -
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry
Kapelios, Chris J.; Laroche, Cécile; Crespo-Leiro, María Generosa; Anker, Stefan; Coats, Andrew J.S.; Díaz-Molina, Beatriz; Filippatos, Gerasimos; Lainscak, Mitja; Maggioni, Aldo P.; McDonagh, Theresa A.; Mebazaa, Alexandre; Metra, Marco; Moura, Brenda; Mullens, Wilfried; Piepoli, Massimo F.; Rosano, Giuseppe; Ruschitzka, Frank; Seferovic, Petar M.; Lund, Lars H. (Willey Online Library, 2020-04-01)[Abstract] Aims. Guidelines recommend down-titration of loop diuretics (LD) once euvolaemia is achieved. In outpatients with heart failure (HF), we investigated LD dose changes in daily cardiology practice, agreement ... -
Brachial pulse pressure in acute heart failure. Results of the Heart Failure Registry
Bonapace, Stefano; Rossi, Andrea; Laroche, Cécile; Crespo-Leiro, María Generosa; Piepoli, Massimo F.; Coats, Andrew J. S.; Dahlström, Ulf; Malek, Filip; Macarie, Cezar; Temporelli, Pier Luigi; Maggioni, Aldo P.; Tavazzi, Luigi (Willey Online Library, 2019-12-09)[Abstract] Aims To investigate the still uncertain independent prognostic impact of pulse pressure (PP) in acute heart failure (HF), in particular across the left ventricular ejection fraction (EF) phenotypes, and the ... -
Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term Registry
Kapłon-Cieślicka, Agnieszka; Laroche, Cécile; Crespo-Leiro, María Generosa; Coats, Andrew J.S.; Anker, Stefan; Filippatos, Gerasimos; Maggioni, Aldo P.; Hage, Camilla; Lara-Padrón, Antonio; Fucili, Alessandro; Drożdż, Jarosław; Seferovic, Petar M.; Rosano, Giuseppe; Mebazaa, Alexandre; McDonagh, Theresa A.; Lainscak, Mitja; Ruschitzka, Frank; Lund, Lars H. (Wiley Online Library, 2020-07-02)[Abstract] Aims. In hospitalized patients with a clinical diagnosis of acute heart failure (HF) with preserved ejection fraction (HFpEF), the aims of this study were (i) to assess the proportion meeting the 2016 European ... -
Long‐term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long‐Term Registry
Mebazaa, Alexandre; Motiejunaite, Justina; Gayat, Etienne; Crespo-Leiro, María Generosa; Lund, Lars H.; Maggioni, Aldo P.; Chioncel, Ovidiu; Akiyama, Eiichi; Harjola, Veli-Pekka; Seferovic, Petar M.; Laroche, Cécile; Sanz Julve, Marisa; Roig, Eulàlia; Ruschitzka, Frank; Filippatos, Gerasimos (Wiley, 2017-10-08)[Abstract] Aims. The aim of this study was to assess long‐term safety of intravenous cardiovascular agents—vasodilators, inotropes and/or vasopressors—in acute heart failure (AHF). Methods and results. The European Society ... -
Performance of prognostic risk scores in chronic heart failure patients enrolled in the European Society of Cardiology Heart Failure long-term registry
Canepa, Marco; Fonseca, Candida; Chioncel, Ovidiu; Laroche, Cécile; Crespo-Leiro, María Generosa; Coats, Andrew J.S.; Mebazaa, Alexandre (Elsevier, 2018-06)[Abstract] Objectives. This study compared the performance of major heart failure (HF) risk models in predicting mortality and examined their utilization using data from a contemporary multinational registry. Background. ... -
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
Kapelios, Chris J.; Lainscak, Mitja; Savarese, Gianluigi; Laroche, Cécile; Seferovic, Petar; Ruschitzka, Frank; Coats, Andrew; Anker, Stefan; Crespo-Leiro, María Generosa; Filippatos, Gerasimos; Piepoli, Massimo; Rosano, Giuseppe; Zanolla, Luisa; Aguiar, Carlos; Murin, Jan; Leszek, Przemyslaw; McDonagh, Theresa; Maggioni, Aldo P.; Lund, Lars H. (Wiley, 2019-05-27)[Abstract] Aims: To assess the proportion of patients with heart failure and reduced ejection fraction (HFrEF) who are eligible for sacubitril/valsartan (LCZ696) based on the European Medicines Agency/Food and Drug ... -
Sex‐ and Age‐Related Differences in the Management and Outcomes of Chronic Heart Failure: an Analysis of Patients from the ESC HFA EORP Heart Failure Long‐Term Registry
Lainscak, Mitja; Milinković, Ivan; Polovina, Marija; Crespo-Leiro, María Generosa; Lund, Lars H.; Anker, Stefan; Laroche, Cécile; Ferrari, Roberto; Coats, Andrew J.S.; McDonagh, Theresa A.; Filippatos, Gerasimos; Maggioni, Aldo P.; Piepoli, Massimo Francesco; Rosano, Giuseppe; Ruschitzka, Frank; Simić, Dragan; Ašanin, Milika; Eicher, Jean‐Christophe; Yilmaz, Mehmet Birhan; Seferovic, Petar M. (Willey, 2019-12-20)[Abstract] Aims. This study aimed to assess age‐ and sex‐related differences in management and 1‐year risk for all‐cause mortality and hospitalization in chronic heart failure (HF) patients. Methods and results. Of ... -
Unravelling the Interplay Between Hyperkalaemia, Renin–Angiotensin–Aldosterone Inhibitor Use and Clinical Outcomes. Data From 9222 Chronic Heart Failure Patients of the ESC‐HFA‐EORP Heart Failure Long‐Term Registry
Rossignol, Patrick; Lainscak, Mitja; Crespo-Leiro, María Generosa; Laroche, Cécile; Piepoli, Massimo Francesco; Filippatos, Gerasimos; Rosano, Giuseppe; Savarese, Gianluigi; Anker, Stefan; Seferovic, Petar M.; Ruschitzka, Frank; Coats, Andrew J.S.; Mebazaa, Alexandre; McDonagh, Theresa; Sahuquillo-Martínez, Ana; Penco, María; Maggioni, Aldo P.; Lund, Lars H. (Willey Online Library, 2020-04-03)[Abstract] Aims. We assessed the interplay between hyperkalaemia (HK) and renin–angiotensin–aldosterone system inhibitor (RAASi) use, dose and discontinuation, and their association with all‐cause or cardiovascular death ...